Source - LSE Regulatory
RNS Number : 8019T
Belluscura PLC
29 November 2021
 

 

Belluscura PLC

("Belluscura" or "Company")

 

Exercise of Warrants and Total Voting Rights

 

LONDON, U.K. AND PLANO, TX, U.S. (29 November 2021). Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that it has received notification from a warrant holder to exercise warrants over 179,537 shares in the share capital of Belluscura ("the Warrant Shares") at exercise prices of 13 pence (139,537 shares) and 15 pence (40,000 shares). The consideration for the exercise of the Warrant Shares amounts, in aggregate, to a cash value of £24,139.81.

 

The Warrant Shares were allotted on 26 November 2021. Application has been made for the Warrant Shares to be admitted to trading on AIM ("Admission"), and Admission is expected to be on or around 2 December 2021. These shares will rank pari passu with the ordinary shares of the Company in issue.

 

Total voting rights

 

The Company's total issued capital, after the issue of the Warrant Shares, will be 113,486,938 ordinary shares. As the Company does not hold any shares in Treasury, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.

 

Belluscura plc

www.belluscura.com

Robert Rauker, Chief Executive Officer

via Walbrook PR

Anthony Dyer, Chief Financial Officer




SPARK Advisory Partners Ltd (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin




Dowgate Capital Ltd (Broker & Bookrunner)

Tel: +44 (0)20 3903 7715

James Serjeant / Nicholas Chambers




Walbrook PR Ltd (Media & Investor Relations)

Tel: +44 (0)20 7933 8780 or belluscura@walbrookpr.com

Paul McManus / Sam Allen

Mob: +44 (0)7980 541 893 / +44 (0)7502 558 258

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEEAEFPAFDFFAA
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJBell logo

Related Charts

Belluscura PLC (BELL)

-1.00p (-5.13%)
delayed 16:57PM